Clearside BioMedical Inc (CLSD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The companys pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlusion and DME - Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearsides proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc (CLSD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises US$8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Partnerships 20
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
Licensing Agreements 23
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Equity Offering 25
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc - Key Competitors 31
Clearside BioMedical Inc - Key Employees 32
Clearside BioMedical Inc - Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 08, 2018: Clearside Biomedical announces second quarter 2018 financial results and provides corporate update 34
May 09, 2018: Clearside Biomedical Announces First Quarter 2018 Financial Results 37
Mar 14, 2018: Clearside Biomedical Reports Fourth Quarter 2017 Financial Results 38
Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update 41
Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update 43
May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update 45
Mar 14, 2017: Clearside Biomedical Announces Fourth Quarter And Full Year 2016 Financial Results 47
Corporate Communications 49
Sep 27, 2018: Clearside Biomedical appoints Jeffrey Edwards to board of directors 49
Sep 11, 2018: Clearside Biomedical names Leslie Zacks as General Counsel and Chief Compliance Officer 50
Feb 26, 2018: Clearside Biomedical Appoints William Humphries As Board Chairman And Brion Raymond As Chief Commercial Officer 51
Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors 53
Jan 04, 2017: Clearside Biomedical Appoints Richard Beckman, M.D., as Chief Medical Officer 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List Of Tables


Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises US$8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc, Key Competitors 31
Clearside BioMedical Inc, Key Employees 32

List Of Figures


Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10

Clearside BioMedical Inc (CLSD) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that developing treatments for vision impairment associated with uveitic macular edema. The companys pipeline products include Uveitis, macular edema associated with

USD 250 View Report

Clearside Biomedical Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Clearside Biomedical Inc Company Profile is a detailed strategic and analytical report on Clearside Biomedical Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Ondine Biomedical Inc - Product Pipeline Analysis, 2018 Update

Ondine Biomedical Inc (Ondine), formerly Ondine Biopharma Corp, a subsidiary of 0902337 B.C. Ltd, is a non-antibiotic anti-infective therapies developer for bacterial, viral, and fungal infections. The companys products include

USD 750 View Report

Saladax Biomedical Inc - Product Pipeline Analysis, 2019 Update

Saladax Biomedical Inc - Product Pipeline Analysis, 2019 Update

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available